SEARCH

SEARCH BY CITATION

References

  • 1
    Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:10661074.
  • 2
    Cunningham F, Leveno K, Bloom S, Hauth J, Rouse D, Spong C: Williams Obstetrics, 23rd edn. New York, Mc Graw Hill Medical, 2010.
  • 3
    Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y: The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28:192209.
  • 4
    Ahn H, Park J, Gilman-Sachs A, Kwak-Kim J: Immunologic characteristics of preeclampsia, a comprehensive review. Am J Reprod Immunol 2011; 65:377394.
  • 5
    Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S: Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000; 6:8895.
  • 6
    Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y: Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody “87G” and anti-cytokeratin antibody “CAM5.2”. Am J Reprod Immunol 1996; 36:349358.
  • 7
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355:9921005.
  • 8
    Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2:656663.
  • 9
    Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12:10651074.
  • 10
    Molvarec A, Ito M, Shima T, Yoneda S, Toldi G, Stenczer B, Vasarhelyi B, Rigo J Jr, Saito S: Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia. Am J Obstet Gynecol 2010; 203:567 e561–568.
  • 11
    Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649658.
  • 12
    Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y: Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145:48384845.
  • 13
    Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I: Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006; 291:R1085R1093.
  • 14
    Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S: Evolution of non-cytotoxic uterine natural killer cells. Am J Reprod Immunol 2008; 59:425432.
  • 15
    Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S: Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:40854092.
  • 16
    Dunk C, Ahmed A: Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol 2001; 16:359375.
  • 17
    Molvarec A, Blois SM, Stenczer B, Toldi G, Tirado-Gonzalez I, Ito M, Shima T, Yoneda S, Vasarhelyi B, Rigo J Jr, Saito S: Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia. Clin Immunol 2011; 139:4856.
  • 18
    Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767773.
  • 19
    Kwak-Kim JY, Gilman-Sachs A, Kim CE: T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005; 88:6479.
  • 20
    Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353356.
  • 21
    Carter LL, Dutton RW: Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol 1995; 155:10281031.
  • 22
    Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G: Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998; 161:58215824.
  • 23
    Saito S, Sakai M: Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161173.
  • 24
    Rein DT, Schondorf T, Gohring UJ, Kurbacher CM, Pinto I, Breidenbach M, Mallmann P, Kolhagen H, Engel H: Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsia. J Reprod Immunol 2002; 54:133142.
  • 25
    Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:59495956.
  • 26
    Saito S, Nakashima A, Shima T, Ito M: Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010; 63:601610.
  • 27
    Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL: Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol 2005; 35:30543063.
  • 28
    Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, Oleszczuk J: The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 2002; 48:381386.
  • 29
    Sargent IL, Borzychowski AM, Redman CW: NK cells and pre-eclampsia. J Reprod Immunol 2007; 76:4044.
  • 30
    Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, Moretta L, Dimasi N: Human natural killer cell receptors: insights into their molecular function and structure. J Cell Mol Med 2003; 7:376387.
  • 31
    Fukui A, Ntrivalas E, Gilman-Sachs A, Kwak-Kim J, Lee SK, Levine R, Beaman K: Expression of natural cytotoxicity receptors and a2V-ATPase on peripheral blood NK cell subsets in women with recurrent spontaneous abortions and implantation failures. Am J Reprod Immunol 2006; 56:312320.
  • 32
    Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O: Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001; 31:26802689.
  • 33
    Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y, Davis DM, Strominger JL, Yewdell JW, Porgador A: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:10551060.
  • 34
    Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O: Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J Immunol 2009; 182:22212230.
  • 35
    Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Hoglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Karre K, Shibuya A, Carbone E, Colucci F: NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009; 119:12511263.
  • 36
    Cagnano E, Hershkovitz O, Zilka A, Bar-Ilan A, Golder A, Sion-Vardy N, Bogdanov-Berezovsky A, Mandelboim O, Benharroch D, Porgador A: Expression of ligands to NKp46 in benign and malignant melanocytes. J Invest Dermatol 2008; 128:972979.
  • 37
    Manaster I, Mizrahi S, Goldman-Wohl D, Sela HY, Stern-Ginossar N, Lankry D, Gruda R, Hurwitz A, Bdolah Y, Haimov-Kochman R, Yagel S, Mandelboim O: Endometrial NK cells are special immature cells that await pregnancy. J Immunol 2008; 181:18691876.
  • 38
    Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, Kimura H, Mizunuma H: Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol 2011; 90:105110.
  • 39
    Zhang Y, Zhao A, Wang X, Shi G, Jin H, Lin Q: Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Fertil Steril 2008; 90:19311937.
  • 40
    Fukui A, Ntrivalas E, Fukuhara R, Fujii S, Mizunuma H, Gilman-Sachs A, Beaman K, Kwak-Kim J: Correlation between natural cytotoxicity receptors and intracellular cytokine expression of peripheral blood NK cells in women with recurrent pregnancy losses and implantation failures. Am J Reprod Immunol 2009; 62:371380.
  • 41
    Mandelboim O, Reyburn HT, Vales-Gomez M, Pazmany L, Colonna M, Borsellino G, Strominger JL: Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996; 184:913922.
  • 42
    Rajagopalan S, Long EO: Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 2005; 201:10251029.
  • 43
    Moffett A, Hiby SE: How Does the maternal immune system contribute to the development of pre-eclampsia? Placenta 2007; 28(Suppl A):S51S56.
  • 44
    Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534543.
  • 45
    Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957965.
  • 46
    Fukui A: NK cells and its role in reproduction. Am J Reprod Immunol 2010; 64:1.
  • 47
    Fukui A: Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy losses, implantation failures or preeclampsia. J Reprod Immunol 2010; 86:14.
  • 48
    Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE: Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197:244 e241–248.
  • 49
    Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH: First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53:812818.
  • 50
    Forte P, Lilienfeld BG, Baumann BC, Seebach JD: Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 2005; 175:54635470.
  • 51
    Wiesmayr S, Webber SA, Macedo C, Popescu I, Smith L, Luce J, Metes D: Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur J Immunol 2012; 42:541550.
  • 52
    Bachmayer N, Sohlberg E, Sundstrom Y, Hamad RR, Berg L, Bremme K, Sverremark-Ekstrom E: Women with pre-eclampsia have an altered NKG2A and NKG2C receptor expression on peripheral blood natural killer cells. Am J Reprod Immunol 2009; 62:147157.
  • 53
    Park DW, Lee HJ, Park CW, Hong SR, Kwak-Kim J, Yang KM: Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am J Reprod Immunol 2010; 63:173180.
  • 54
    Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345:13401342.
  • 55
    Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, Chung-Bang H, Ng SC, Beaman KD, Mantouvalos HP, Beer AE: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16:855861.
  • 56
    Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y: Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol 1999; 41:413422.
  • 57
    Saito S: Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87103.
  • 58
    Moffett A, Regan L, Braude P: Natural killer cells, miscarriage, and infertility. BMJ 2004; 329:12831285.
  • 59
    Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW: Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction 2006; 131:583589.